O Keefe Stevens Advisory Inc. Buys 37,718 Shares of Sotera Health Company $SHC

O Keefe Stevens Advisory Inc. raised its stake in shares of Sotera Health Company (NASDAQ:SHC) by 4.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 838,114 shares of the company’s stock after purchasing an additional 37,718 shares during the quarter. Sotera Health accounts for about 3.3% of O Keefe Stevens Advisory Inc.’s investment portfolio, making the stock its 13th biggest position. O Keefe Stevens Advisory Inc. owned about 0.29% of Sotera Health worth $15,497,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. GAMMA Investing LLC grew its position in Sotera Health by 7.4% during the third quarter. GAMMA Investing LLC now owns 10,055 shares of the company’s stock worth $186,000 after buying an additional 694 shares in the last quarter. Farther Finance Advisors LLC raised its holdings in Sotera Health by 20.4% in the 3rd quarter. Farther Finance Advisors LLC now owns 17,770 shares of the company’s stock valued at $329,000 after acquiring an additional 3,009 shares in the last quarter. Two Seas Capital LP raised its holdings in Sotera Health by 4.7% in the 3rd quarter. Two Seas Capital LP now owns 6,111,053 shares of the company’s stock valued at $112,993,000 after acquiring an additional 275,000 shares in the last quarter. ABS Direct Equity Fund LLC lifted its position in shares of Sotera Health by 150.0% in the 2nd quarter. ABS Direct Equity Fund LLC now owns 125,000 shares of the company’s stock worth $2,219,000 after acquiring an additional 75,000 shares during the period. Finally, Darsana Capital Partners LP lifted its position in shares of Sotera Health by 3.8% in the 2nd quarter. Darsana Capital Partners LP now owns 27,000,000 shares of the company’s stock worth $479,250,000 after acquiring an additional 1,000,000 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Price Performance

NASDAQ:SHC traded up $0.26 during trading hours on Friday, reaching $18.09. The company had a trading volume of 409,907 shares, compared to its average volume of 2,724,001. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33. The stock has a 50-day moving average of $18.70 and a two-hundred day moving average of $17.00. Sotera Health Company has a one year low of $13.09 and a one year high of $19.85. The firm has a market capitalization of $5.16 billion, a PE ratio of 31.75 and a beta of 1.85.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The company had revenue of $321.38 million during the quarter, compared to analysts’ expectations of $309.70 million. During the same period last year, the business earned $0.20 earnings per share. The business’s revenue was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Analysts forecast that Sotera Health Company will post 0.87 earnings per share for the current year.

Insider Activity

In related news, Chairman Michael B. Jr. Petras sold 850,000 shares of Sotera Health stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the completion of the transaction, the chairman directly owned 3,969,393 shares of the company’s stock, valued at $73,433,770.50. This trade represents a 17.64% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Michael P. Rutz sold 150,000 shares of the company’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the sale, the insider directly owned 334,279 shares in the company, valued at $6,297,816.36. This represents a 30.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 1,294,515 shares of company stock valued at $23,999,528 over the last three months. 15.36% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

SHC has been the topic of a number of research reports. Piper Sandler restated an “overweight” rating and set a $25.00 price objective on shares of Sotera Health in a research report on Tuesday, September 8th. Citigroup raised their target price on Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. UBS Group set a $19.00 price target on shares of Sotera Health in a research note on Wednesday, June 24th. Wall Street Zen raised shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 29th. Finally, Weiss Ratings upgraded shares of Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Eight analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Sotera Health has an average rating of “Moderate Buy” and an average price target of $21.50.

Sotera Health Company Profile

Sotera Health Company (NASDAQ:SHC) is a global provider of healthcare services focused on sterilization, laboratory testing and infection prevention. The company serves medical device manufacturers, pharmaceutical companies, biotechnology businesses, hospitals and other healthcare organizations.

Sotera Health operates through three primary businesses. Sterigenics provides outsourced sterilization and medical device services using technologies such as ethylene oxide, gamma irradiation and electron beam processing.